Nahid Bhadelia, M.D., MALD
White House COVID-19 Response Team
Nahid Bhadelia, M.D., MALD is the senior policy advisor for global COVID-19 response with the White House COVID-19 Response Team. She is an infectious diseases physician, the founding director of BU Center for Emerging Infectious Diseases Policy and Research and an associate director of the National Emerging Infectious Diseases Laboratories (NEIDL), a state-of-the-art maximum containment research facility at BU.
Over the last decade, Bhadelia designed and served as the medical director of the Special Pathogens Unit (SPU) at Boston Medical Center, a medical unit designed to care for patients with highly communicable diseases, and a state designated Ebola Treatment Center. She has prior and ongoing experience in health system response to pathogens such as H1N1, Zika, Lassa fever, Marburg virus disease, COVID-19 and Mpox at the state, national and global levels, including medical countermeasure evaluation, diagnostic positioning, infection control policy development and healthcare worker training.
Bhadelia has experience with direct patient care, outbreak response and medical countermeasures research during multiple Ebola virus disease outbreaks in West and East Africa. She previously served as the clinical lead of (and now advises on) a DOD-funded viral hemorrhagic fever research group in Uganda, entitled Joint Mobile Emerging Disease Intervention Clinical Capability (JMEDICC) program. Bhadelia codirects the National Institutes of Health’s Fogarty International Center–funded research training program in Liberia, titled Boston University and University of Liberia Emerging and Epidemic Virus Research (BULEEVR). She was an NBC News medical contributor from 2020-2022.
Over the last decade, Bhadelia designed and served as the medical director of the Special Pathogens Unit (SPU) at Boston Medical Center, a medical unit designed to care for patients with highly communicable diseases, and a state designated Ebola Treatment Center. She has prior and ongoing experience in health system response to pathogens such as H1N1, Zika, Lassa fever, Marburg virus disease, COVID-19 and Mpox at the state, national and global levels, including medical countermeasure evaluation, diagnostic positioning, infection control policy development and healthcare worker training.
Bhadelia has experience with direct patient care, outbreak response and medical countermeasures research during multiple Ebola virus disease outbreaks in West and East Africa. She previously served as the clinical lead of (and now advises on) a DOD-funded viral hemorrhagic fever research group in Uganda, entitled Joint Mobile Emerging Disease Intervention Clinical Capability (JMEDICC) program. Bhadelia codirects the National Institutes of Health’s Fogarty International Center–funded research training program in Liberia, titled Boston University and University of Liberia Emerging and Epidemic Virus Research (BULEEVR). She was an NBC News medical contributor from 2020-2022.